Clinical Trials Logo

Resistant Meningiomas clinical trials

View clinical trials related to Resistant Meningiomas.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02333565 Completed - Clinical trials for Resistant Meningiomas

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

CEVOREM
Start date: January 22, 2015
Phase: Phase 2
Study type: Interventional

To determine if combination of everolimus and octreotide exert an anti-tumoral activity in recurrent and/or aggressive meningiomas growth with limited adverse effects.